[1]
McGrogan A,Franssen CF,de Vries CS, The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2011 Feb [PubMed PMID: 21068142]
[2]
Wiggins RC, The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney international. 2007 Jun [PubMed PMID: 17410103]
[3]
D'Agati VD,Fogo AB,Bruijn JA,Jennette JC, Pathologic classification of focal segmental glomerulosclerosis: a working proposal. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004 Feb [PubMed PMID: 14750104]
[4]
Yu H,Artomov M,Brähler S,Stander MC,Shamsan G,Sampson MG,White JM,Kretzler M,Miner JH,Jain S,Winkler CA,Mitra RD,Kopp JB,Daly MJ,Shaw AS, A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. The Journal of clinical investigation. 2016 Apr 1 [PubMed PMID: 26927868]
[5]
Savin VJ,Sharma M,Zhou J,Gennochi D,Fields T,Sharma R,McCarthy ET,Srivastava T,Domen J,Tormo A,Gauchat JF, Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family. Journal of immunology research. 2015 [PubMed PMID: 26146641]
[6]
Delville M,Sigdel TK,Wei C,Li J,Hsieh SC,Fornoni A,Burke GW,Bruneval P,Naesens M,Jackson A,Alachkar N,Canaud G,Legendre C,Anglicheau D,Reiser J,Sarwal MM, A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Science translational medicine. 2014 Oct 1 [PubMed PMID: 25273097]
[7]
Königshausen E,Sellin L, Circulating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed Candidates. BioMed research international. 2016 [PubMed PMID: 27200372]
[8]
Meehan SM,Kim L,Chang A, A spectrum of morphologic lesions of focal segmental glomerulosclerosis by Columbia criteria in human immunodeficiency virus infection. Virchows Archiv : an international journal of pathology. 2012 Apr [PubMed PMID: 22388441]
[9]
Chandra P,Kopp JB, Viruses and collapsing glomerulopathy: a brief critical review. Clinical kidney journal. 2013 Feb [PubMed PMID: 23372939]
[10]
Markowitz GS,Appel GB,Fine PL,Fenves AZ,Loon NR,Jagannath S,Kuhn JA,Dratch AD,D'Agati VD, Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. Journal of the American Society of Nephrology : JASN. 2001 Jun [PubMed PMID: 11373339]
[11]
Petersen CE,Amaral S,Frosch E, Lithium-induced nephrotic syndrome in a prepubertal boy. Journal of child and adolescent psychopharmacology. 2008 Apr [PubMed PMID: 18439118]
[12]
Letavernier E,Bruneval P,Mandet C,Duong Van Huyen JP,Péraldi MN,Helal I,Noël LH,Legendre C, High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clinical journal of the American Society of Nephrology : CJASN. 2007 Mar [PubMed PMID: 17699432]
[13]
Brenner BM,Mackenzie HS, Nephron mass as a risk factor for progression of renal disease. Kidney international. Supplement. 1997 Dec [PubMed PMID: 9407439]
[14]
Kriz W,Lemley KV, Mechanical challenges to the glomerular filtration barrier: adaptations and pathway to sclerosis. Pediatric nephrology (Berlin, Germany). 2017 Mar [PubMed PMID: 27008645]
[15]
Sim JJ,Batech M,Hever A,Harrison TN,Avelar T,Kanter MH,Jacobsen SJ, Distribution of Biopsy-Proven Presumed Primary Glomerulonephropathies in 2000-2011 Among a Racially and Ethnically Diverse US Population. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2016 Oct [PubMed PMID: 27138468]
[16]
Kitiyakara C,Eggers P,Kopp JB, Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004 Nov [PubMed PMID: 15492947]
[17]
Kriz W,Lemley KV, A potential role for mechanical forces in the detachment of podocytes and the progression of CKD. Journal of the American Society of Nephrology : JASN. 2015 Feb [PubMed PMID: 25060060]
[18]
Kriz W,Gretz N,Lemley KV, Progression of glomerular diseases: is the podocyte the culprit? Kidney international. 1998 Sep [PubMed PMID: 9734594]
[19]
Stokes MB,D'Agati VD, Morphologic variants of focal segmental glomerulosclerosis and their significance. Advances in chronic kidney disease. 2014 Sep [PubMed PMID: 25168828]
[20]
Thomas DB,Franceschini N,Hogan SL,Ten Holder S,Jennette CE,Falk RJ,Jennette JC, Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney international. 2006 Mar [PubMed PMID: 16518352]
[21]
Stokes MB,Markowitz GS,Lin J,Valeri AM,D'Agati VD, Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum. Kidney international. 2004 May [PubMed PMID: 15086908]
[22]
Stokes MB,Valeri AM,Markowitz GS,D'Agati VD, Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney international. 2006 Nov [PubMed PMID: 17021605]
[23]
Moudgil A,Nast CC,Bagga A,Wei L,Nurmamet A,Cohen AH,Jordan SC,Toyoda M, Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney international. 2001 Jun [PubMed PMID: 11380814]
[24]
Tomlinson L,Boriskin Y,McPhee I,Holwill S,Rice P, Acute cytomegalovirus infection complicated by collapsing glomerulopathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2003 Jan [PubMed PMID: 12480980]
[25]
Markowitz GS,Nasr SH,Stokes MB,D'Agati VD, Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis. Clinical journal of the American Society of Nephrology : CJASN. 2010 Apr [PubMed PMID: 20203164]
[26]
Baradhi KM,Gary Abuelo J,Stillman IE, The Case: diabetic nephropathy in a nondiabetic smoker? Kidney international. 2012 Nov [PubMed PMID: 23128123]
[27]
Banfi G,Moriggi M,Sabadini E,Fellin G,D'Amico G,Ponticelli C, The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clinical nephrology. 1991 Aug [PubMed PMID: 1934660]
[28]
Cattran DC,Appel GB,Hebert LA,Hunsicker LG,Pohl MA,Hoy WE,Maxwell DR,Kunis CL, A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney international. 1999 Dec [PubMed PMID: 10594798]
[29]
Fornoni A,Sageshima J,Wei C,Merscher-Gomez S,Aguillon-Prada R,Jauregui AN,Li J,Mattiazzi A,Ciancio G,Chen L,Zilleruelo G,Abitbol C,Chandar J,Seeherunvong W,Ricordi C,Ikehata M,Rastaldi MP,Reiser J,Burke GW 3rd, Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Science translational medicine. 2011 Jun 1 [PubMed PMID: 21632984]
[30]
Chun MJ,Korbet SM,Schwartz MM,Lewis EJ, Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. Journal of the American Society of Nephrology : JASN. 2004 Aug [PubMed PMID: 15284302]
[31]
Troyanov S,Wall CA,Miller JA,Scholey JW,Cattran DC, Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. Journal of the American Society of Nephrology : JASN. 2005 Apr [PubMed PMID: 15716334]